Home › Cases › Stevens-Johnson Syndrome / TEN
SJS / TEN
Stevens-Johnson Syndrome / TEN
6 questions
Question 1 · Recognition
Correct answer: Stevens-Johnson syndrome / toxic epidermal necrolysis — a dermatological emergency
Why
SJS/TEN is drug-induced epidermal death:
- Prodrome (fever, sore throat/eyes) then painful dusky rash → flaccid blisters → sheet-like detachment
- Positive Nikolsky sign — skin shears with lateral pressure
- Mucosal involvement (mouth, eyes, genitals) in >90%
- Classic culprits: allopurinol, anticonvulsants (lamotrigine, carbamazepine, phenytoin), sulfonamides, NSAIDs — typically 1–4 weeks after starting
Key point
Painful dusky rash + mucositis + Nikolsky positive after a new drug = SJS/TEN. Skin pain out of proportion is the alarm.
Question 2 · Classification & Severity
Correct answer: SJS <10%, SJS/TEN overlap 10–30%, TEN >30% — severity by SCORTEN
Why
Classification by % epidermal detachment:
- SJS <10%, SJS/TEN overlap 10–30%, TEN >30%
- SCORTEN (age, malignancy, HR, BSA, urea, bicarbonate, glucose) predicts mortality — calculated in the first 24h
- Her 12% = overlap — mortality risk is significant (TEN overall ~30%)
Key point
<10% SJS, 10–30% overlap, >30% TEN. SCORTEN in the first 24h predicts mortality and guides placement.
Question 3 · The Single Most Important Step
Correct answer: Stop the culprit drug — allopurinol — immediately and document the allergy
Why
Stopping the culprit drug is the single intervention proven to improve survival:
- Earlier withdrawal = better outcomes
- Document the allergy prominently — re-exposure is potentially fatal
- Check for cross-reacting drugs (e.g. between aromatic anticonvulsants)
- Immunomodulation (IVIG, ciclosporin) is specialist-led and secondary
Key point
Stop the culprit drug NOW — the one intervention that clearly improves SJS/TEN survival.
Question 4 · Supportive Care
Correct answer: IV fluids (burns-style losses), analgesia, keep warm, non-adherent dressings, strict fluid balance
Why
Manage like a major burn:
- IV fluids — large insensible losses (though less than equivalent burns)
- Analgesia — skin pain is severe; often needs opioids
- Warm environment (thermoregulation fails), non-adherent dressings, avoid unnecessary handling
- No prophylactic antibiotics — treat proven infection only (masking sepsis markers)
- Catheter + strict balance
Key point
Treat as a burn: fluids, analgesia, warmth, non-adherent dressings — but NO prophylactic antibiotics.
Question 5 · Specialist Referrals
Correct answer: Dermatology (urgent) + burns unit/ITU transfer + same-day ophthalmology + urology/gynae for mucosal care
Why
SJS/TEN needs a multidisciplinary emergency response:
- Dermatology urgently — confirms diagnosis (± biopsy), leads immunomodulation decisions
- Burns unit/ITU for significant detachment — specialist skin care
- Ophthalmology same day — ocular involvement scars and blinds; needs lubricants ± amniotic membrane
- Mucosal care — urology/gynae input to prevent strictures
Key point
Derm + burns/ITU + same-day ophthalmology. Eyes and mucosa determine long-term morbidity — involve specialists day one.
Question 6 · Prevention & Genetics
Correct answer: HLA-B*58:01 carriage (higher in Han Chinese, Thai, Korean populations) markedly raises allopurinol SJS/TEN risk — screening is recommended in high-risk groups; starting doses should be low, especially in CKD
Why
Pharmacogenetics matter:
- HLA-B*58:01 strongly associates with allopurinol severe cutaneous reactions — screen before starting in Han Chinese, Thai, Korean patients
- HLA-B*15:02 — carbamazepine SJS in South-East Asian populations
- High starting doses and renal impairment increase risk — start allopurinol at 50–100mg
- Report to MHRA Yellow Card
Key point
HLA-B*58:01 predicts allopurinol SJS/TEN — screen at-risk ethnicities, start low, report via Yellow Card.
Case complete
Practice on this page does not update your app progress. Open the browser app if you want its learning tools and progress record.